Clinical Trial Update: Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants [Phase 1]

View source ↗

Summary

Phase 1 single-dose pharmacokinetic study of [14C]-IDV184001AN in healthy adult males, sponsored by Indivior Inc., related to Opioid Use Disorder. Results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• [14C]-IDV184001AN

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2025-02-13